SOURCE: Beleave Inc.

Beleave Inc.

March 29, 2016 08:00 ET

Beleave Research Project Awarded Grant From the Natural Sciences and Engineering Research Council of Canada, and Beleave Opens Online Store

TORONTO, ON--(Marketwired - March 29, 2016) - Beleave Inc. (CSE: BE) (the "Corporation" or "Beleave") is pleased to announce that a $25,000 Engage grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) has been awarded for a collaborative research project between Dr. Lesley Campbell, associate professor for Ryerson University's Department of Chemistry and Biology, and Beleave's wholly-owned subsidiary First Access Medical Inc. ("FAM"). The NSERC-funded research which will be carried out at Ryerson University, and aims to develop high quality medicinal cannabis extracts. These funds will help cover research salaries and other research costs for a 6 month period beginning March 31, 2016.

All intellectual property stemming from the NSERC-funded research will belong to Beleave, and is the first of many planned research collaborations Beleave will be pursuing to develop high quality cannabis-based medicines to meet specifically identified medicinal needs.

"Through its Engage program, NSERC encourages new and exciting university-industry partnerships, providing critically important resources that drive scientific innovation in Canada," commented Beleave CEO, Dr. Roger Ferreira. "We are extremely grateful to collaborate on this NSERC-funded project, and to be given the opportunity to further scientific investigation of cannabis-based medicines, which we feel will have significant medicinal importance for Canada."

E-Commerce

Beleave is pleased to announce that it has officially opened its online store. Beleave will commence by offering high quality Arizer brand vaporizers to its customers, and plans to roll out additional product offerings on a bi-weekly basis. Visit www.beleave.com and choose shop from the drop down menu.

About Beleave

Beleave Inc. is a biotech company committed to becoming a licensed producer under the Marihuana for Medical Purposes Regulations (the "MMPR"). Beleave's wholly-owned subsidiary First Access Medical Inc. ("FAM") has applied for a licence to cultivate and sell medical marihuana pursuant to the MMPR. As of the date hereof, FAM has successfully advanced past the security clearance stage and is currently in the review stage of the licensing process. Beleave's purpose built facility is located near Hamilton, Ontario.

About Ryerson

Ryerson University is Canada's leader in innovative, career-oriented education. Urban, culturally diverse and inclusive, the university is home to more than 41,500 students, including 2,400 master's and PhD students, 3,200 faculty and staff, and nearly 170,000 alumni worldwide. For more information, visit www.ryerson.ca

About NSERC

NSERC invests over $1 billion each year in natural sciences and engineering research in Canada. Our investments deliver discoveries -- valuable world-firsts in knowledge claimed by a brain trust of over 11,000 professors. Our investments enable partnerships and collaborations that connect industry with discoveries and the people behind them. Researcher-industry partnerships established by NSERC help inform R&D, solve scale-up challenges, and reduce the risks of developing high-potential technology.

NSERC also provides scholarships and hands-on training experience for more than 30,000 post-secondary students and post-doctoral fellows. These young researchers will be the next generation of science and engineering leaders in Canada.

Image Available: http://www.marketwire.com/library/MwGo/2016/3/29/11G089394/Images/ryersonUni-021e85eb62789ee9b2fe5978febc9044.jpg
Image Available: http://www.marketwire.com/library/MwGo/2016/3/29/11G089394/Images/NSERC-0bfc18253deba7e0960311669816ec90.jpg

Contact Information

  • For more information contact:
    Sebastian de Kloet
    Phone: 1 (905) 979 - 5173
    Email: Sebastian@beleave.com